JP2019505568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505568A5 JP2019505568A5 JP2018549402A JP2018549402A JP2019505568A5 JP 2019505568 A5 JP2019505568 A5 JP 2019505568A5 JP 2018549402 A JP2018549402 A JP 2018549402A JP 2018549402 A JP2018549402 A JP 2018549402A JP 2019505568 A5 JP2019505568 A5 JP 2019505568A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- syndrome
- compound according
- aliphatic group
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C=CCc1ccccc1)I Chemical compound C*(C=CCc1ccccc1)I 0.000 description 4
- YSAXEHWHSLANOM-UHFFFAOYSA-N CC1=Cc2ccccc2C1 Chemical compound CC1=Cc2ccccc2C1 YSAXEHWHSLANOM-UHFFFAOYSA-N 0.000 description 1
- OVRKATYHWPCGPZ-UHFFFAOYSA-N CC1CCOCC1 Chemical compound CC1CCOCC1 OVRKATYHWPCGPZ-UHFFFAOYSA-N 0.000 description 1
- BEEIHTCHVRPYOV-VOTSOKGWSA-N NS/C=C/c1ccccc1 Chemical compound NS/C=C/c1ccccc1 BEEIHTCHVRPYOV-VOTSOKGWSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562264925P | 2015-12-09 | 2015-12-09 | |
| US62/264,925 | 2015-12-09 | ||
| PCT/US2016/065857 WO2017100594A1 (en) | 2015-12-09 | 2016-12-09 | Bicyclic inhibitors of pad4 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019505568A JP2019505568A (ja) | 2019-02-28 |
| JP2019505568A5 true JP2019505568A5 (enExample) | 2020-01-16 |
| JP6932136B2 JP6932136B2 (ja) | 2021-09-08 |
Family
ID=59013640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549402A Active JP6932136B2 (ja) | 2015-12-09 | 2016-12-09 | Ｐａｄ４の二環式阻害剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9963448B2 (enExample) |
| EP (2) | EP3885342B1 (enExample) |
| JP (1) | JP6932136B2 (enExample) |
| KR (1) | KR102729670B1 (enExample) |
| CN (1) | CN109069869B (enExample) |
| AR (1) | AR107032A1 (enExample) |
| AU (1) | AU2016366398A1 (enExample) |
| BR (1) | BR112018011709A2 (enExample) |
| CA (1) | CA3007639A1 (enExample) |
| EA (1) | EA201891251A1 (enExample) |
| ES (2) | ES2877543T3 (enExample) |
| IL (1) | IL259794A (enExample) |
| MX (1) | MX2018006632A (enExample) |
| SG (1) | SG11201804668UA (enExample) |
| TW (1) | TW201726674A (enExample) |
| UY (1) | UY37018A (enExample) |
| WO (1) | WO2017100594A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016185279A1 (en) * | 2015-05-21 | 2016-11-24 | Glaxosmithkline Intellectual Property Development Limited | Benzoimidazole derivatives as pad4 inhibitors |
| SG11201807021UA (en) * | 2016-02-23 | 2018-09-27 | Padlock Therapeutics Inc | Heteroaryl inhibitors of pad4 |
| US10703741B2 (en) | 2016-07-27 | 2020-07-07 | Padlock Therapeutics, Inc. | Covalent inhibitors of PAD4 |
| KR102502992B1 (ko) | 2016-09-12 | 2023-02-24 | 패들락 테라퓨틱스, 인코포레이티드 | Pad4의 헤테로아릴 억제제 |
| CN110194770B (zh) * | 2018-02-26 | 2022-08-09 | 药捷安康(南京)科技股份有限公司 | 肽酰精氨酸脱亚胺酶抑制剂及其用途 |
| EP3833440A1 (en) * | 2018-08-08 | 2021-06-16 | Bristol-Myers Squibb Company | Indole and azaindole inhibitors of pad enzymes |
| ES2956090T3 (es) | 2018-08-08 | 2023-12-13 | Bristol Myers Squibb Co | Inhibidores de bencimidazol de enzimas PAD |
| MX2021001471A (es) * | 2018-08-08 | 2021-04-28 | Bristol Myers Squibb Co | Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4). |
| ES2929200T3 (es) * | 2018-08-08 | 2022-11-25 | Bristol Myers Squibb Co | Tienopirroles sustituidos como inhibidores de PAD4 |
| KR20210146370A (ko) | 2019-03-28 | 2021-12-03 | 루핀 리미티드 | Sting 효능제로서의 매크로사이클릭 화합물 |
| TW202115083A (zh) * | 2019-09-27 | 2021-04-16 | 大陸商南京藥捷安康生物科技有限公司 | 肽醯精胺酸脫亞胺酶抑制劑及其用途 |
| CN115298175B (zh) * | 2020-02-06 | 2024-05-07 | 百时美施贵宝公司 | 可用作免疫抑制剂的大环pad4抑制剂 |
| TW202140477A (zh) | 2020-02-12 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 雜環ｐａｄ４抑制劑 |
| MX2022013615A (es) | 2020-04-30 | 2022-11-16 | Gilead Sciences Inc | Inhibidores de macrociclo de peptidilarginina deiminasas. |
| WO2022040267A1 (en) | 2020-08-19 | 2022-02-24 | Bristol-Myers Squibb Company | 1h-pyrrolo[3,2-c]pyridine and 1h-pyrrolo[2,3-c]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis |
| US12492188B2 (en) | 2020-08-19 | 2025-12-09 | Bristol-Myers Squibb Company | 1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis |
| EP4267562A1 (en) | 2020-12-22 | 2023-11-01 | Gilead Sciences, Inc. | Inhibitors of peptidylarginine deiminases |
| CN112618546B (zh) * | 2020-12-22 | 2022-03-01 | 陈昊 | Pad4抑制剂在制备放射治疗增敏药物方面的应用 |
| TW202233174A (zh) | 2020-12-22 | 2022-09-01 | 美商基利科學股份有限公司 | 肽基精胺酸去亞胺酶之抑制劑 |
| AU2023387505B2 (en) * | 2022-11-24 | 2026-03-05 | Helios Huaming Biopharma Co., Ltd. | Selenium containing heterocycle compounds and use thereof |
| WO2025024265A1 (en) | 2023-07-21 | 2025-01-30 | Bristol-Myers Squibb Company | Methods of assessing citrullination and activity of pad4 modulators |
| WO2025181830A2 (en) * | 2024-03-01 | 2025-09-04 | Jubilant Epipad LLC | Polyheterocyclic compounds as peptidyl arginine deiminase 4 (pad4) inhibitors |
| WO2026020127A2 (en) | 2024-07-19 | 2026-01-22 | Bristol-Myers Squibb Company | Methods of assessing citrullination and activity of pad2 modulators |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20012060A1 (it) * | 2001-10-05 | 2003-04-05 | Recordati Chem Pharm | Nuovi eterocilcli n-acilati |
| US6897208B2 (en) | 2001-10-26 | 2005-05-24 | Aventis Pharmaceuticals Inc. | Benzimidazoles |
| WO2004041277A1 (en) | 2002-11-01 | 2004-05-21 | Merck & Co., Inc. | Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| EP2234487A4 (en) | 2007-12-19 | 2011-09-07 | Scripps Research Inst | ANILIDES AND ANALOGUES AS INHIBITORS OF RHO KINASE |
| WO2012061390A2 (en) * | 2010-11-01 | 2012-05-10 | The Penn State Research Foundation | Therapeutic compositions and methods |
| JP5721484B2 (ja) | 2011-03-17 | 2015-05-20 | 富士フイルム株式会社 | 重合性液晶組成物、それを用いた高分子材料および光学異方性フィルム、並びに重合性液晶化合物 |
| WO2013052263A2 (en) | 2011-09-16 | 2013-04-11 | Microbiotix, Inc. | Antifungal compounds |
| WO2013157021A1 (en) | 2012-04-20 | 2013-10-24 | Advinus Therapeutics Limited | Bicyclic compounds, compositions and medicinal applications thereof |
| CA2874303C (en) | 2012-06-11 | 2020-10-13 | Ucb Biopharma Sprl | Tnf -alpha modulating benz imidazoles |
| EA025186B1 (ru) | 2012-06-29 | 2016-11-30 | Пфайзер Инк. | НОВЫЕ 4-(ЗАМЕЩЕННЫЙ АМИНО)-7Н-ПИРРОЛО[2,3-d]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LRRK2 |
| RU2611010C2 (ru) | 2012-07-26 | 2017-02-17 | Глаксо Груп Лимитед | 2-(Азаиндол-2-ил)бензимидазолы в качестве ингибиторов PAD4 |
| WO2016185279A1 (en) * | 2015-05-21 | 2016-11-24 | Glaxosmithkline Intellectual Property Development Limited | Benzoimidazole derivatives as pad4 inhibitors |
-
2016
- 2016-12-07 AR ARP160103778A patent/AR107032A1/es unknown
- 2016-12-08 TW TW105140709A patent/TW201726674A/zh unknown
- 2016-12-09 CA CA3007639A patent/CA3007639A1/en not_active Abandoned
- 2016-12-09 CN CN201680081403.0A patent/CN109069869B/zh active Active
- 2016-12-09 EP EP21171167.6A patent/EP3885342B1/en active Active
- 2016-12-09 JP JP2018549402A patent/JP6932136B2/ja active Active
- 2016-12-09 EP EP16873928.2A patent/EP3386590B1/en active Active
- 2016-12-09 ES ES16873928T patent/ES2877543T3/es active Active
- 2016-12-09 EA EA201891251A patent/EA201891251A1/ru unknown
- 2016-12-09 MX MX2018006632A patent/MX2018006632A/es unknown
- 2016-12-09 ES ES21171167T patent/ES3007582T3/es active Active
- 2016-12-09 US US15/374,159 patent/US9963448B2/en active Active
- 2016-12-09 UY UY0001037018A patent/UY37018A/es unknown
- 2016-12-09 WO PCT/US2016/065857 patent/WO2017100594A1/en not_active Ceased
- 2016-12-09 BR BR112018011709A patent/BR112018011709A2/pt not_active Application Discontinuation
- 2016-12-09 SG SG11201804668UA patent/SG11201804668UA/en unknown
- 2016-12-09 AU AU2016366398A patent/AU2016366398A1/en not_active Abandoned
- 2016-12-09 KR KR1020187019382A patent/KR102729670B1/ko active Active
-
2018
- 2018-06-04 IL IL259794A patent/IL259794A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019505597A5 (enExample) | ||
| JP2019525936A5 (enExample) | ||
| ES2295682T3 (es) | Derivados de pirimidina y su uso como modulares de cb2. | |
| US11471471B2 (en) | Aqueous oral pharmaceutical suspension compositions | |
| EP3259253B1 (en) | Sulfonylureas and related compounds and use of same | |
| CN109790162A (zh) | Pad4的共价抑制剂 | |
| RU2673889C1 (ru) | Стабильная кристаллическая форма ii апремиласта, не содержащая сольваты, и способ ее получения | |
| CN109311851A (zh) | 二氢嘧啶基苯并氮杂*甲酰胺化合物 | |
| BR112020002906A2 (pt) | novos compostos de sulfonamida-carboxamida | |
| US11390612B2 (en) | Polymorphic forms of Afatinib free base and Afatinib dimaleate | |
| ES2730474T3 (es) | Proceso para la preparación de ivacaftor y solvatos de este | |
| BR112017007953B1 (pt) | Forma cristalina ii do bissulfato inibidor de jak quinase, seu uso e seu método de preparação, e composição farmacêutica | |
| ES2680146T3 (es) | Hidrocloruro de rilpivirina | |
| TW200806652A (en) | N-hydroxyacrylamide compounds | |
| WO2020138481A1 (ja) | ピロリジン化合物の結晶 | |
| CN112789087B (zh) | Pad酶的苯并咪唑抑制剂 | |
| JP2000505450A (ja) | キノロン類およびこれらの治療的使用 | |
| UA77969C2 (en) | Piperidine derivatives and their use for modulating ccr5 receptor activity, process for their manufacture, pharmaceutical composition and intermediate compound | |
| CN115385893A (zh) | 与吡啶酰基哌啶5-ht1f激动剂相关的组合物和方法 | |
| WO2024179422A1 (zh) | Aficamten的共晶及其制备方法和用途 | |
| WO2004018434A1 (en) | Pyrimidine compounds | |
| WO2022002859A1 (en) | Substituted n-phenylacetamides having p2x4 receptor antagonistic activity | |
| ES3052235T3 (en) | A new vamorolone preparation exhibiting improved solubility | |
| KR20080032135A (ko) | 호흡기 질환의 치료에 유용한 케모카인 수용체조절인자로서의 신규 피페리딘 유도체 | |
| JP2013503823A (ja) | （ｓ）‐ｎ‐メチル‐３‐（１‐ナフチルオキシ）‐３‐（２‐チエニル）プロピルアミン塩酸塩（デュロキセチン）の結晶化方法 |